Effectiveness of iPRF Injections in Temporomandibular Joints Degeneration Management

PHASE2/PHASE3Enrolling by invitationINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

January 24, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Temporomandibular DisorderTemporomandibular Joint DisordersTemporomandibular ArthritisTemporomandibular Joint Osteoarthritis
Interventions
BIOLOGICAL

Injectable platelet-rich fibrin

Intra-articular injection of injectable platelet-rich fibrin into temporomandibular joint/joints with diagnosed mild to moderate degenerative joint disease.

BIOLOGICAL

Platelet-rich plasma

Intra-articular injection of platelet-rich plasma into temporomandibular joint/joints with diagnosed mild to moderate degenerative joint disease.

Trial Locations (1)

Unknown

Wroclaw Medical University, Wroclaw

All Listed Sponsors
lead

Wroclaw Medical University

OTHER